Patent details

301144 Product Name: Apalutamide

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301144
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3533792
Status:
SPC granted but not yet in force
Application number:
301144
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1342
Marketing Authorization Type:
EEA
Marketing Authorization Date:
16/01/2019
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
03/11/2021
First Marketing Authorization date:
16/01/2019
Grant date:
20/03/2025
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
03/11/2021
SPC/SPC Extension Expiration Date:
15/01/2034
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
12/09/2022
 
 

 

Name:
Aragon Pharmaceuticals, Inc.
Address:
10990 Wilshire Blvd. Suite 440, 90024, Los Angeles, CA, United States of America (US)

From:
03/11/2021
 
 

 

Name:
Sloan Kettering Institute For Cancer Research
Address:
1275 York Avenue, New York, NY 10065, United States of America (US)

Historical Applicant/holder

From:
03/11/2021
To:
12/09/2022

 

Name:
Aragon Pharmaceuticals, Inc.
Address:
10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024, United States of America (US)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
09/01/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
03/11/2021
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
09/01/2025

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
13/25
Publication date:
26/03/2025
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
45/21
Publication date:
10/11/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202202288A
Date Registered:
12/09/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/06/2033
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
20/03/2025 Outgoing Correspondence Decision grant 2 PDF /2/4/7/9/3/0800739742/docs/301144_15_648914l504a.pdf
20/03/2025 Certificate Certificate 1 PDF /2/4/7/9/3/0800739742/docs/301144_16_spcmedcertificate20250320135432454.pdf
26/02/2025 Incoming Correspondence Electronic Accompanying letter incoming document 3 PDF /2/4/7/9/3/0800739742/docs/301144_14_incomingcorrespondenceelectronic20250228034005600.pdf
27/11/2024 Outgoing Correspondence Letter to applicant 3 PDF /2/4/7/9/3/0800739742/docs/301144_12_632906l173.pdf
11/11/2024 SPC Documents Annex SPC 1 PDF /2/4/7/9/3/0800739742/docs/301144_13_supplprotectioncertificate20241111040033425.pdf
08/06/2022 Outgoing Correspondence Letter to applicant 1 PDF /2/4/7/9/3/0800739742/docs/301144_10_483971l173.pdf
30/05/2022 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /2/4/7/9/3/0800739742/docs/301144_11_incomingcorrespondencepaper20220531101804926.pdf
22/02/2022 Outgoing Correspondence Letter to applicant 2 PDF /2/4/7/9/3/0800739742/docs/301144_7_463803l173.pdf
21/02/2022 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /2/4/7/9/3/0800739742/docs/301144_6_incomingcorrespondencepaper20220221042242831.pdf
07/12/2021 Outgoing Correspondence Letter to applicant 3 PDF /2/4/7/9/3/0800739742/docs/301144_5_448947l173.pdf
04/11/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /2/4/7/9/3/0800739742/docs/301144_8_444205l174.pdf
03/11/2021 SPC Documents Annex SPC 2 PDF /2/4/7/9/3/0800739742/docs/301144_0_supplprotectioncertificate20211103045055502.pdf
03/11/2021 SPC Documents Marketing Authorization SPC 3 PDF /2/4/7/9/3/0800739742/docs/301144_1_supplprotectioncertificate20211103045055403.pdf
03/11/2021 SPC Documents Annex SPC 28 PDF /2/4/7/9/3/0800739742/docs/301144_2_supplprotectioncertificate20211103045055481.pdf
03/11/2021 SPC Documents Annex SPC 3 PDF /2/4/7/9/3/0800739742/docs/301144_3_supplprotectioncertificate20211103045055461.pdf
03/11/2021 Application Form First filed application form 3 PDF /2/4/7/9/3/0800739742/docs/301144_4_applicationform20211103045055346.pdf
03/11/2021 SPC Documents Summary of the characteristics of the product 14 PDF /2/4/7/9/3/0800739742/docs/301144_9_supplprotectioncertificate20211103045055429.pdf